相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography
Henriette de Loor et al.
JOURNAL OF CHROMATOGRAPHY A (2009)
Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial
Natalie Meert et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Short-term treatment with sevelamer increases serum fetuin-A concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients
Kayser Caglar et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
A bench to bedside view of uremic toxins
Raymond Vanholder et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Hyperphosphatemia of chronic kidney disease
Keith A. Hruska et al.
KIDNEY INTERNATIONAL (2008)
Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis
Takashi Takei et al.
NEPHRON CLINICAL PRACTICE (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Nonphosphate-Binding Effects of Sevelamer-Are They of Clinical Relevance?
Nicola Marangon et al.
SEMINARS IN DIALYSIS (2008)
Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification
Willi Jahnen-Dechent et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Association of serum fetuin-A levels with mortality in dialysis patients
M. M. H. Hermans et al.
KIDNEY INTERNATIONAL (2007)
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders
Andrea Galassi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
The case against calcium-based phosphate binders
Sharon M. Moe et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients
B Bammens et al.
KIDNEY INTERNATIONAL (2006)
Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice
O Phan et al.
CIRCULATION (2005)
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
GA Block et al.
KIDNEY INTERNATIONAL (2005)
Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients
F Koiwa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2005)
Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum
H de Loor et al.
CLINICAL CHEMISTRY (2005)
The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease
WG Goodman
SEMINARS IN DIALYSIS (2004)
Vascular calcification in chronic kidney disease
WG Goodman et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
The phosphatonin pathway: New insights in phosphate homeostasis
SC Schiavi et al.
KIDNEY INTERNATIONAL (2004)
The serum protein α2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
C Schäfer et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis:: a cross-sectional study
M Ketteler et al.
LANCET (2003)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
Albumin-corrected calcium and ionized calcium in stable haemodialysis patients
CM Clase et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
